← Leaderboards
Kelly J Kelleher
Research Inst Nationwide Children'S Hosp
$6,824,478
Attributed
$10,194,412
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.6M · FY2005–23$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$10,194,412 · 5
By mechanism
UH3$6,034,927 · 1
R01$3,310,544 · 2
UG3$704,941 · 1
R03$144,000 · 1
Top collaborators
- Natasha Slesnick5 shared
Most similar at Research Inst Nationwide Children'S Hosp
Same institution · by research overlap
- Lara Beth McKenzie$2,087,106
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsServicesYouthAffectCommunitiesHealthcareProviderResearch PersonnelBaseProgramsEffectivenessInterestMental DisordersLinkGrowthDesignGeneral PopulationMeetingsNational Institute Of Mental Health (U.S.)BehaviorComplementHeterogeneityCharacteristicsEvidence Base
Grant awards (18)
Supplement to HOME Trial: Role of Justice Involvement in Implementation and Effectiveness of Housing First for Youth Experiencing Homelessness$169,233
UH3 · FY2023 · DA
Preventing Substance Misuse and Substance Use Disorder by Examining Service Provider Interactions, Discrimination, Ethnic Identity, Sexual Orientation Identity, and Housing First Outcomes$234,642
UH3 · FY2021 · DA
Prevention of OUD: The HOME (Housing, Opportunities, Motivation and Engagement) Randomized Trial$4,922,920
UH3 · FY2020 · DA
Revision to the HOME Trial: Suicide Treatment Education and Prevention (HOME + STEP)$708,132
UH3 · FY2020 · DA
Prevention of OUD: The HOME (Housing, Opportunities, Motivation and Engagement) Randomized Trial$704,941
UG3 · FY2019 · DA
Cross Design Synthesis: Combining Evidence About Antidepressants and Suicidality$291,182
R01 · FY2010 · MH · contact PI
Cross Design Synthesis: Combining Evidence About Antidepressants and Suicidality$265,452
R01 · FY2010 · MH · contact PI
Cross Design Synthesis: Combining Evidence About Antidepressants and Suicidality$294,518
R01 · FY2009 · MH · contact PI
Cross Design Synthesis: Combining Evidence About Antidepressants and Suicidality$289,055
R01 · FY2008 · MH · contact PI
The Spatio-Temporal Diffusion of Psychotropic Medication to Rural Children$72,000
R03 · FY2008 · MH · contact PI
Cross Design Synthesis: Combining Evidence About Antidepressants and Suicidality$286,065
R01 · FY2007 · MH · contact PI
Trial of Automated Risk Appraisal for Adolescents$205,136
R01 · FY2007 · DA · contact PI
The Spatio-Temporal Diffusion of Psychotropic Medication to Rural Children$72,000
R03 · FY2007 · MH · contact PI
Trial of Automated Risk Appraisal for Adolescents$454,979
R01 · FY2006 · DA · contact PI
Cross Design Synthesis: Combining Evidence About Antidepressants and Suicidality$301,058
R01 · FY2006 · MH · contact PI
Trial of Automated Risk Appraisal for Adolescents$393,598
R01 · FY2005 · DA
Trial of Automated Risk Appraisal for Adolescents$73,939
R01 · FY2005 · DA
Trial of Automated Risk Appraisal for Adolescents$455,562
R01 · FY2004 · DA